Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Titel:
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Auteur:
Winther, Stine Braendegaard Liposits, Gabor Skuladottir, Halla Hofsli, Eva Shah, Carl-Henrik Poulsen, Laurids Østergaard Ryg, Jesper Osterlund, Pia Berglund, Åke Qvortrup, Camilla Glimelius, Bengt Sorbye, Halfdan Pfeiffer, Per